Publications
11
Citations
193
Est. group size
—
Recurring co-author estimate
Active years
8
Publishing since 2019
Evan W. Neczypor's research spans two distinct areas: the cardiovascular effects of nicotine vaping in animal models, and the use of DNA-based biomarkers (specifically a chemical modification called 5-hydroxymethylcytosine) found in blood samples to detect and monitor osteosarcoma, a type of bone cancer. This work aims to develop less invasive tools for tracking cancer status and understanding health risks from vaping.
Publication output has been low and irregular over the past decade, with several gap years, but shows a recent uptick with multiple outputs appearing in 2025 and 2026.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- 5-hydroxymethylcytosine profiles in circulating cell-free DNA associate with disease status in patients with osteosarcoma
npj Precision Oncology · 2026
- 5-hydroxymethylcytosine profiles in circulating cell-free DNA associate with disease status in patients with osteosarcoma
Research Square · 2025
- Identifying osteosarcoma signatures in cell free DNA using 5-hydroxymethylcytosine profiling.
Journal of Clinical Oncology · 2023
- VAPING WITH NICOTINE REDUCES LEFT VENTRICULAR CARDIAC FUNCTION IN ADOLESCENT MALE MICE
The Knowledge Bank (The Ohio State University) · 2021
- Molecular Neurodegeneration×1
- Function×1
- The Annual Review of Pharmacology and Toxicology×1
- Circulation Research×1
- The FASEB Journal×1
- Thivanka Muthumalage
Medicine · Purdue University West Lafayette
- Bukola Usidame
Medicine · Purdue University West Lafayette
- Ahmad El‐Hellani
Medicine · The Ohio State University
- Marielle C. Brinkman
Medicine · The Ohio State University
- Alayna P. Tackett
Medicine · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile